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MEASURING HIV ASSOCIATED MORTALITY IN AFRICA
Does the Spectrum model accurately predict trends in
adult mortality? Evaluation of model estimates using
empirical data from a rural HIV community cohort
study in north-western Tanzania
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Introduction: Spectrum epidemiological models are used by UNAIDS to provide global, regional and national
HIV estimates and projections, which are then used for evidence-based health planning for HIV services.
However, there are no validations of the Spectrum model against empirical serological and mortality data
from populations in sub-Saharan Africa.
Methods: Serologic, demographic and verbal autopsy data have been regularly collected among over 30,000
residents in north-western Tanzania since 1994. Five-year age-specific mortality rates (ASMRs) per 1,000
person years and the probability of dying between 15 and 60 years of age (45Q15,) were calculated and
compared with the Spectrum model outputs. Mortality trends by HIV status are shown for periods before the
introduction of antiretroviral therapy (19941999, 20002005) and the first 5 years afterwards (20052009).
Results: Among 3034 year olds of both sexes, observed ASMRs per 1,000 person years were 13.33 (95% CI:
10.7516.52) in the period 19941999, 11.03 (95% CI: 8.8413.77) in 20002004, and 6.22 (95% CI; 4.75
8.15) in 20052009. Among the same age group, the ASMRs estimated by the Spectrum model were 10.55,
11.13 and 8.15 for the periods 19941999, 20002004 and 20052009, respectively. The cohort data, for both
sexes combined, showed that the 45Q15 declined from 39% (95% CI: 2755%) in 1994 to 22% (95% CI: 17
29%) in 2009, whereas the Spectrum model predicted a decline from 43% in 1994 to 37% in 2009.
Conclusion: From 1994 to 2009, the observed decrease in ASMRs was steeper in younger age groups than
that predicted by the Spectrum model, perhaps because the Spectrum model under-estimated the ASMRs in
3034 year olds in 199499. However, the Spectrum model predicted a greater decrease in 45Q15 mortality
than observed in the cohort, although the reasons for this over-estimate are unclear.
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T
anzania, like many other sub-Saharan African
countries, has experienced high adult mortality
due to HIV/AIDS. The adult mortality rate is the
probability of dying between age 15 and 60 years and is
known to demographers as 45Q15. In Tanzania 45Q15 was
estimated as 45% in 1995, 45% in 2000, and 40% in 2005
(1), but in a study in northern Tanzania in 1999, the 45Q15
was estimated as 49% for men and 46% for women (2).
There is strong evidence that all-cause, adult mortality
rates elsewhere in East Africa have declined over the past
10 years, with Uganda showing that all-cause adult
mortality declined by 25% following the roll-out of
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anti-retroviral therapy (ART) (3). Other sites in Africa
compare all-cause adult mortality 26 years following
ART roll-out with pre-ART period and show a decrease
of 42% in Karonga, Malawi; 21% in Kisesa, Tanzania;
and 21% in UMkhanyakude, South Africa (4), although
the overall pattern in South Africa may not show much
decrease in all-cause adult mortality (5). However, HIV is
still a leading cause of adult death in many countries in
East and Southern Africa (6).
In Tanzania in 1996, in a population aged 1554 years
with a 4% prevalence of HIV, 35% of all deaths occurred
in HIV positives (7). In Zambia in 1999 in two townships
with a 15% prevalence of HIV among adults, 53% of all
deaths were attributable to HIV (8) while in Zimbabwe, in
2006, 61% of all adult deaths were attributable to HIV
(9). However, HIV-attributable mortality has declined in
Tanzania since 2004 (C. Kanjala et al., unpublished
data), and the most obvious reason for the decline in
all-cause and HIV-attributable mortality is the availabil-
ity of ART (10).
Due to the weaknesses in vital registration and health
information systems in developing countries, little infor-
mation is available for planning of health services.
National and regional health planners depend on esti-
mates and projections from demographic and epidemio-
logical models. Even if there were reliable demographic
data in these countries, good, validated models would be
needed to study the potential impact of health interven-
tions. The Spectrum model, developed by the Futures
Institute, uses information from national or sentinels,
population-based surveys, in order to estimate key para-
meters of the HIV epidemic (11, 12). Estimating HIV
incidence from prevalence relies on an accurate progres-
sion and survival model for HIV, which has thus far been
validated against a limited number of data sets. Problems
with data quality and model specification can lead to
incorrect projections. Demographic surveillance sites that
also collect HIV data can be used to verify the model
specification, and validate the out-parameters of the
Spectrum model, thus improving the model fit, and the
understanding of the HIV epidemic curves applied to
the data.
This paper describes trends and patterns in age-specific
mortality rates (ASMRs) and in the index of adult
mortality (45Q15) in Kisesa HIV cohort study in north-
western Tanzania from 1999 to 2009. The paper then
compares these observed mortality rates and 45Q15 with
estimates from the Spectrum model.
Methods
Population data
The Kisesa HIV cohort study is based on the population
of seven villages located approximately 20 km east of
Mwanza City in north-western Tanzania. The seven
villages range from urbanised, roadside settlements near
the ward’s trading centre to remote rural settlements,
with 95% of the population belonging to the Sukuma
tribe, the largest ethnic group in Tanzania. The main
economic activities are small-scale farming and petty
trade of both agricultural and livestock products, while a
minority of residents are fishermen. The demographic
surveillance system (DSS) conducts a household count
every 36 months to record new residents through births
and in-migration, as well as those lost to the cohort
through death and out-migration. The DSS began in
1994, with a population of 19,350, and by 2011 the
population had increased to 34,000 (13). Over the same
period (19942011), six serological surveys have been
conducted, 23 years apart, to monitor trends in the HIV
epidemic in adults aged 15 years and over in the
population (14, 15). Dry blood spots are collected and
two independent enzyme-linked immunosorbent assays
are used, according to Tanzanian guidelines to determine
those who are HIV positive.
Data management and statistical analysis
All data from community cohort were entered using
Census and Surveys Processing (CSPro) software (U.S.
Bureau of the Census & ORC Macro’s MEASURE DHS
project, 2000), and transferred to STATA Version12 (Stata
Corp., College Station, Texas) for analysis. ASMRs were
calculated by dividing the number of deaths observed by the
person years of follow-up, for each sex and 5-year age group
in the resident population. Adult mortality was summarized
as 45Q15, which is obtained by multiplying the survival
derived from the ASMRs. The 45Q15 measure was obtained
separately for males and females in the cohort, and based
on the serological HIV status of those who had been tested,
the 45Q15 measure was obtained for HIV-positive, HIV-
negative and HIV-unknown groups. Parameters, ASME
and 45Q15, estimated from the cohort data are shown with
95% confidence intervals (95% CI) derived from the Poisson
distribution for deaths in this cohort.
The Spectrum model
The Spectrum model analyses existing country-specific
data to estimate the current and future population
structure and health of the people in the country. It
comprises of different, integrated policy modules such as
the Demographical Projection (DemProj), AIDS Impact
(AIM), Family Planning (FamPlan), Child Survival
(LIST) among others. Each module relies on program-
matic input data and demographical information ob-
tained from DemProj (which in turns bases its projection
on data from the UN Population Division) to produce
indicators for a given public health area.
AIM is at the root of the Spectrum estimates for HIV-
attributable mortality. It consists of three independent
sub-models: mother-to-child transmission, child HIV and
adult HIV. AIM projects the consequences of HIV
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incidence trends, including the number of people living
with HIV, number of new infections, number of pregnant
women infected with HIV, and mortality due to AIDS.
It is widely used to forecast near-term treatment and
prevention of mother-to-child transmission (PMTCT)
needs. In addition to the role AIM plays in HIV program
planning, it is also used to estimate the impact of HIV
prevention programs, such as the impact of expanding
PMTCT and ART programs.
The Spectrum model used the general patterns of the
HIV epidemic in Tanzania, with changes to specifically
model the age and sex structure in Kisesa. The specific
input parameters to the Spectrum model were obtained
from a workshop in 2012 with members of the network
for Analysis of Longitudinal Population-based HIV data
in Africa (ALPHA). Details of data analysis work by
the ALPHA network are given by Maher et al. (16).
The structure of the Spectrum modelling and the general
parameters are described elsewhere (17).
Ethical issues
Individual informed consent was obtained from sero
survey study participants. Research activities in the
Kisesa cohort study were granted ethics approval by the
Tanzanian National Research Ethics Review Sub-com-
mittee (NatREC) and the London School of Hygiene and
Tropical Medicine (LSHTM) ethics committee.
Results
Adult ASMRs
Figure 1 shows the ASMRs for three periods (19941999,
20002004, 20052009). ASMRs per 1,000 person years
among those aged 3034 were 13.33 (95% CI: 10.75
16.52) in the period 19941999, 11.03 (95% CI: 8.84
13.77) in 20002004, and 6.22 (95% CI: 4.758.15) in
20052009. Overall all-cause mortality rates in Kisesa are
lower in the period 20052009 than in previous periods
for all age groups, although the 95% confidence intervals
are wide and the differences for any age group may not be
significant. In all periods, all-cause mortality increased
with age, with ASMRs for three periods (19941999,
20002004 and 20052009) shown separately for men
and women (Table 1). The Spectrum model showed that
ASMRs for adults aged 3049 years increased between
the 19941999 period and the 20002004 period. For all
ages the ASMRs decreased between 20002004 and
20052009.
45Q15 mortality trends
Table 2 shows time trends of the index of the proportion
of adult deaths between 15 and 60 years of age (45Q15) by
sex from the Kisesa DSS data, and the Spectrum model
estimates. The probability of dying in the age group
1560 has declined from the year 2000 for both sexes. The
chance of dying in the 1560 age group for both sexes
combined was 39% (95% CI: 2755%) in 1994 and 22%
(95% CI: 1531%) in 2009. Men were found to have a
higher 45Q15 than women across all time periods, though
the 95% confidence intervals overlap in each of the years.
With ART introduction in 2005, there is a consistent
decline in the 45Q15 measure over the next 5 years.
The Spectrum model showed an increase in the 45Q15
measure of mortality for both sexes from 43% in 1994 to
48% in 2000 and a subsequent decline to 37% in 2009.
A similar pattern was shown for women and men
separately, with men having a higher probability of dying
than women across all periods of time. Figure 1 illustrates
trends in the index of adult mortality (45Q15) by sex. The
45Q15 was generally higher in men compared to women
except in a few years. The difference in 45Q15 measure of
Fig. 1. Adult age-specific mortality rates per 1,000 person years (all-cause, both sexes) estimated in Kisesa DSS, 19942009.
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Table 1. Adult age-specific mortality rates per 1,000 person years (all-cause, men and women) from Kisesa cohort data and Spectrum model estimates
19941999 20002004 20052009
Empirical data
Spectrum
estimate Empirical data
Spectrum
estimate Empirical data
Spectrum
estimate
Age
group
Number
of deaths
Number of
person
years
Mortality rate
(95% CI)
Mortality
rate
Number
of deaths
Number of
person
years
Mortality rate
(95% CI)
Mortality
rate
Number
of deaths
Number of
person
years
Mortality rate
(95% CI)
Mortality
rate
Men
1519 19 6,064 3.13 (24.91) 3.06 19 6,275 3.03 (1.934.75) 2.69 15 7,654 1.96 (1.183.25) 2.31
2024 19 4,716 4.03 (2.576.32) 4.86 17 5,029 3.38 (2.15.44) 4.23 20 5,229 3.82 (2.475.93) 3.58
2529 25 3,615 6.91 (4.6710.23) 7.51 24 4,089 5.87 (3.938.76) 6.81 31 4,165 7.44 (5.2310.58) 5.60
3034 49 3,312 14.80 (11.1819.58) 10.24 32 3,344 9.57 (6.7713.53) 10.09 28 4,096 6.84 (4.729.90) 8.07
3539 45 2,654 16.96 (12.6622.71) 13.95 33 2,922 11.30 (8.0315.89) 14.60 37 3,249 11.39 (8.2515.72) 11.85
4044 21 1,903 11.04 (7.216.93) 15.02 49 2,425 20.21 (15.276.74) 16.14 31 2,744 11.30 (7.9416.06) 13.10
4549 31 1,609 19.26 (13.5527.39) 15.38 31 1,688 18.36 (12.9126.11) 16.09 25 2,254 11.09 (7.4916.41) 13.55
5054 25 1,333 18.76 (12.6827.76) 15.29 25 1,290 19.39 (13.128.69) 14.90 31 1,563 19.83 (13.9428.19) 12.73
5559 23 1,005 22.89 (15.2134.44) 25.15 24 1,093 21.95 (14.7132.75) 23.61 21 1,147 18.31 (11.9428.08) 19.97
60 126 2,387 52.79 (40.3369.79) 62.28 138 2,500 55.20 (42.3571.80) 59.95 135 2,801 48.20 (36.3463.88) 56.86
Women
1519 10 5,265 1.90 (1.023.53) 2.59 19 5,774 3.29 (2.15.16) 2.23 17 6,881 2.47 (1.543.97) 1.80
2024 35 4,983 7.02 (5.049.78) 4.81 28 4,954 5.65 (3.98.19) 4.23 10 5,310 1.88 (1.013.5) 3.43
2529 35 4,164 8.40 (6.0311.71) 8.97 36 4,572 7.87 (5.6810.92) 8.71 29 4,767 6.08 (4.238.75) 6.82
3034 46 3,598 12.78 (9.5817.07) 10.85 46 3,728 12.34 (9.2416.47) 12.17 25 4,423 5.65 (3.828.37) 9.44
3539 25 2,619 9.55 (6.4514.13) 12.15 40 3,164 12.64 (9.2717.24) 14.16 28 3,402 8.23 (5.6811.92) 11.87
4044 22 2,059 10.69 (7.0416.23) 11.48 30 2,436 12.31 (8.6117.61) 13.04 25 2,995 8.35 (5.6412.35) 10.94
4549 18 1,566 11.50 (7.2418.25) 14.00 21 1,884 11.15 (7.2717.1) 14.80 23 2,379 9.67 (6.4214.55) 12.35
5054 19 1,368 13.89 (8.8621.78) 14.30 20 1,406 14.22 (9.1822.04) 13.74 19 1,733 10.97 (6.9917.19) 11.30
5559 19 1,079 17.62 (11.2427.62) 13.84 20 1,186 16.87 (10.8826.14) 12.63 18 1,363 13.21 (8.3220.97) 10.71
60 151 2,866 52.69 (40.2169.00) 55.60 132 3,113 42.40 (36.3148.81) 53.60 139 3,612 38.48 (33.454497) 51.03
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mortality between empirical data and the modelled
estimate ranged from 0.03 to 0.16 among men and 0.01
to 0.17 among women. Figure 3 illustrates how the two
data sources, which are empirical versus modelled data
for index of adult mortality (45Q15) by sex and calendar
year, compare to each other.
Adult mortality (45Q15) trends by HIV status
Figure 2 illustrates trends in 45Q15 by HIV status sep-
arately for men and women. The highest 45Q15 for men
was reported in 1999 (58%, 95%CI: 4670%) whilst the
highest 45Q15 for women was in 2000 (42%, 95%CI: 34
51%). 45Q15 for HIV-positive adults was consistently
higher than HIV-negative adults across all time periods.
Adults with unknown sero status had higher 45Q15 than
HIV-negatives but lower than HIV-positive adults. The
trend was the same for both men and women. Although
not conclusive, there was a downward trend of 45Q15
when both sexes were combined regardless of the sero
status. This downtrend was more pronounced among
the HIV-positive females than among the HIV-positive
males.
Discussion
Adult ASMRs in Kisesa peaked during the mid-1990s
and declined during the periods from 2000 onwards. As
expected ASMRs increased with increasing age, and the
observed pattern of ASMRs corresponds to the expected
mortality patterns in HIV infected adults (18). ART
became available in Tanzania in 2005 through the care
and treatment clinics (CTC) and the first members of the
Kisesa cohort were referred to CTC in 2005. Uptake of
ART in this cohort among those estimated to be in need
of treatment has been estimated at less than 3% (19), but
substantial declines in ASMRs have been seen, especially
among adults aged 3049 years. This is similar to the de-
clines in ASMRs seen in other countries in sub-Saharan
Africa following the introduction of ART (3).
The probability of dying between 15 and 60 years of
age (45Q15) also showed a peak in the mid-1990s with
a subsequent decrease of around 25% through to 2009.
The agreement of the empirical data with the Spectrum
model estimates for 45Q15 show the expected epidemic
curve for HIV peaking in the mid-1990s, and the larger
declines from 2005 due to the introduction of ART in the
community. This analysis shows good agreement between
the outputs from the Spectrum model and the ASMRs and
45Q15 estimated from the empirical data using HIV ser-
ology. The model-based results for these measures of adult
mortality in some population segments are smoothed, and
the empirical results show variation from year to year, due
to the relatively small numbers of deaths observed in this
rural community cohort. Further work is needed to
evaluate the model with community-based mortality
data from other serological and verbal autopsy studies.
For the estimates of 45Q15 in this rural cohort, the
agreement between the serological estimates and those
Table 2. Index of adult mortality (45Q15) by sex and calendar year from Kisesa cohort data and Spectrum model estimates
Men Women Both sexes
Year
Empirical 45Q15
a
(95% CI)
Spectrum
estimates Differenceg
Empirical 45Q15
a
(95% CI)b
Spectrum
estimates Differenceg
Empirical 45Q15
a
(95% CI)
Spectrum
estimates Differenceg
1994 0.43 (0.260.63) 0.47 0.04 0.35 (0.180.61) 0.40 0.05 0.39 (0.270.55) 0.43 0.04
1995 0.30 (0.210.40) 0.48 0.18 0.43 (0.320.55) 0.41 0.02 0.36 (0.290.45) 0.45 0.09
1996 0.42 (0.320.53) 0.49 0.07 0.42 (0.310.54) 0.43 0.01 0.41 (0.340.49) 0.46 0.05
1997 0.53 (0.420.64) 0.50 0.03 0.36 (0.270.48) 0.44 0.08 0.45 (0.380.54) 0.47 0.02
1998 0.37 (0.270.50) 0.50 0.13 0.34 (0.230.48) 0.45 0.11 0.35 (0.280.44) 0.48 0.13
1999 0.58 (0.460.70) 0.50 0.08 0.34 (0.260.45) 0.46 0.12 0.47 (0.390.55) 0.48 0.01
2000 0.46 (0.350.57) 0.50 0.04 0.42 (0.340.51) 0.46 0.04 0.44 (0.370.51) 0.48 0.04
2001 0.42 (0.320.53) 0.49 0.07 0.39 (0.300.50) 0.46 0.07 0.41 (0.340.49) 0.48 0.07
2002 0.33 (0.240.44) 0.49 0.16 0.35 (0.270.45) 0.46 0.11 0.34 (0.280.41) 0.47 0.13
2003 0.45 (0.350.56) 0.48 0.03 0.35 (0.270.46) 0.46 0.11 0.40 (0.330.48) 0.47 0.07
2004 0.43 (0.340.54) 0.47 0.04 0.32 (0.240.43) 0.45 0.13 0.38 (0.320.45) 0.46 0.08
2005 0.40 (0.310.50) 0.46 0.06 0.36 (0.280.46) 0.44 0.12 0.38 (0.320.45) 0.45 0.07
2006 0.35 (0.260.47) 0.45 0.10 0.22 (0.140.32) 0.43 0.11 0.29 (0.220.36) 0.44 0.15
2007 0.46 (0.350.59) 0.43 0.03 0.31 (0.220.41) 0.40 0.09 0.38 (0.310.46) 0.41 0.03
2008 0.30 (0.210.41) 0.40 0.10 0.25 (0.160.36) 0.37 0.12 0.27 (0.200.34) 0.38 0.11
2009 0.26 (0.180.38) 0.38 0.12 0.18 (0.130.26) 0.35 0.17 0.22 (0.170.29) 0.37 0.15
a45q15 denotes probability of dying between 1560 years of age.
bCI denotes the 95% confidence intervals.
gDifferenceSpectrum 45Q15 minus Empirical 45Q15.
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obtained from verbal autopsy using the Inter-VA4 soft-
ware were less convincing. Whereas the serological data
showed a marked drop in the proportion dying in 2005,
after the introduction of ART, the verbal autopsy results
showed little change after 2005 (C. Kanjala et al.,
unpublished data). In this supplement, Oti validates the
Spectrum model against verbal autopsy data interpreted
through Inter-VA4 in Nairobi and concludes that both
HIV and TB deaths from the model need to be included
to give an agreement with the Spectrum results (20). This
may also be the reason for poor correlation between the
empirical and Spectrum-modelled results in Kisesa.
In 2004, Stover et al. validated the Spectrum model
estimates against empirical estimates of mortality from
six population-based studies and concluded that the
model performed well (21). However, there are few
reports of validation of the Spectrum model against
empirical serological data from populations in sub-
Saharan Africa. A previous report noted that model-
based approaches may over-estimate mortality due to
HIV and may therefore over-estimate the decline in
mortality with the introduction of ART (22).
In this analysis, estimated ASMRs in adults from the
empirical data agreed well with the estimates from the
Spectrum model. In particular, the decline in mortality
seen in adults aged 3049 years from 2005 onwards
provides some evidence of the impact of ART in this
population. A pooled analysis of population-based data
in four selected sites in East and Southern Africa de-
picted a similar trend in adult mortality, which is greatly
influenced by the introduction of ART in these areas
(3, 19, 23). These results suggest that mortality trends and
patterns may have been adequately modelled and pre-
dicted by the Spectrum model.
Fig. 2. Index of adult mortality by HIV status and calendar year with 95% confidence intervals.
Fig. 3. Index of adult mortality (45Q15) by sex and calendar year from Kisesa cohort data and Spectrum model estimates.
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The observed data on the probability of dying between
15 and 60 years of age in this analysis were similar to the
estimates from a population-based study in Uganda. In
Uganda, the 45Q15 before 2004 was estimated as 51% for
men (95% CI: 4557%) and 44% for women (95% CI: 39
49%), decreasing from 2005 onwards, to 38% (95% CI:
3344%) for men and 32% (95% CI: 2837%) for women
(3). Although there was a slightly higher overall estimate
of 45Q15 in Uganda compared to these results, there is
a consistent trend in a decreasing 45Q15 following the
introduction of ART.
A comparison of the 45Q15 estimates for those known
to be HIV positive reinforces the conclusion that mor-
tality has decreased, and that a greater decrease has been
observed in women than men. From 2005, empirical data
show that the 45Q15 in women has been declining, in-
dicating that survival in those that are HIV positive has
improved. It is not surprising that women have shown
greater improvements in survival, as it has been shown
that women are more likely to access ART relative to
estimated need for treatment and that they access ART
with higher CD4 counts and better immunological status
(24).
The data for this paper have been taken from demo-
graphic surveillance of vital events in 30,000 people since
1994. With less than 100 deaths per annum between the
ages of 15 and 60 years, there is considerable variation in
the annual adult mortality. Previous studies have shown
that epidemiological models may over-estimate mortality
due to HIV/AIDS, although some deaths may have been
missed from this study due to out-migration. We have
presented the data on ASMRs and 45Q15 in this paper,
and have not shown age adjusted mortality rates, as the
population structure in Kisesa has not changed much
over the 19 years of follow-up, and the age adjusted adult
mortality rate is very similar to the 45Q15 that we present.
Although the size of the decline in all-cause mortality
may differ between the model and the observed data, the
decline from pre-ART to post-ART periods is clear from
both the data and the model outputs.
Conclusion
Most resource-limited countries lack vital registration
data, in order to estimate mortality rates and other
demographic population parameters. This article presents
a fair comparison of mortality estimates generated by the
Spectrum model against empirical data from a long-
standing population-based cohort. From 1994 to 2009,
the observed decrease in ASMRs was steeper in younger
age groups than that predicted by the Spectrum model
perhaps because the Spectrum model under-estimated the
ASMRs in 3034 year olds in 199499. However, the
Spectrum model predicted a greater decrease in 45Q15
mortality than observed in the cohort, although the
reasons for this over-estimate are unclear. These findings
have evidently shown a technical gap to be filled to
improve the Spectrum model such that it can exactly
predict population parameters in setting where empirical
data are scarce but they are needed for health planning.
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